BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 18528930)

  • 1. Etiopathogenesis of primary biliary cirrhosis.
    Lleo A; Invernizzi P; Mackay IR; Prince H; Zhong RQ; Gershwin ME
    World J Gastroenterol; 2008 Jun; 14(21):3328-37. PubMed ID: 18528930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary biliary cirrhosis: a multi-faced interactive disease involving genetics, environment and the immune response.
    Uibo R; Kisand K; Yang CY; Gershwin ME
    APMIS; 2012 Nov; 120(11):857-71. PubMed ID: 23009110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The X and why of xenobiotics in primary biliary cirrhosis.
    Rieger R; Gershwin ME
    J Autoimmun; 2007; 28(2-3):76-84. PubMed ID: 17360156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis.
    Tsuneyama K; Van De Water J; Van Thiel D; Coppel R; Ruebner B; Nakanuma Y; Dickson ER; Gershwin ME
    Hepatology; 1995 Nov; 22(5):1440-6. PubMed ID: 7590661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of antimitochondrial autoantibodies in sera and bile in primary biliary cirrhosis.
    Nishio A; Van de Water J; Leung PS; Joplin R; Neuberger JM; Lake J; Björkland A; Tötterman TH; Peters M; Worman HJ; Ansari AA; Coppel RL; Gershwin ME
    Hepatology; 1997 May; 25(5):1085-9. PubMed ID: 9141421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cholangiocytes in primary biliary cirrhosis.
    Lleo A; Maroni L; Glaser S; Alpini G; Marzioni M
    Semin Liver Dis; 2014 Aug; 34(3):273-84. PubMed ID: 25057951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current concepts in the pathogenesis of primary biliary cirrhosis.
    Charatcharoenwitthaya P; Lindor KD
    Ann Hepatol; 2005; 4(3):161-75. PubMed ID: 16177655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis.
    Irie J; Wu Y; Wicker LS; Rainbow D; Nalesnik MA; Hirsch R; Peterson LB; Leung PS; Cheng C; Mackay IR; Gershwin ME; Ridgway WM
    J Exp Med; 2006 May; 203(5):1209-19. PubMed ID: 16636131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pyruvate dehydrogenase complex as a target autoantigen in primary biliary cirrhosis.
    Nishio A; Coppel R; Ishibashi H; Gershwin ME
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):535-47. PubMed ID: 10976013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis.
    Yeaman SJ; Kirby JA; Jones DE
    Immunol Rev; 2000 Apr; 174():238-49. PubMed ID: 10807520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apotopes and the biliary specificity of primary biliary cirrhosis.
    Lleo A; Selmi C; Invernizzi P; Podda M; Coppel RL; Mackay IR; Gores GJ; Ansari AA; Van de Water J; Gershwin ME
    Hepatology; 2009 Mar; 49(3):871-9. PubMed ID: 19185000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of primary biliary cirrhosis.
    Concepcion AR; Medina JF
    Curr Pharm Des; 2015; 21(18):2401-13. PubMed ID: 25777756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concept on the pathogenesis and treatment of primary biliary cirrhosis.
    Reshetnyak VI
    World J Gastroenterol; 2006 Dec; 12(45):7250-62. PubMed ID: 17143938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies in primary biliary cirrhosis: recent progress in research on the pathogenetic and clinical significance.
    Yamagiwa S; Kamimura H; Takamura M; Aoyagi Y
    World J Gastroenterol; 2014 Mar; 20(10):2606-12. PubMed ID: 24627596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity and primary biliary cirrhosis.
    Mackay IR
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):519-33. PubMed ID: 10976012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novosphingobium aromaticivorans: a potential initiator of primary biliary cirrhosis.
    Kaplan MM
    Am J Gastroenterol; 2004 Nov; 99(11):2147-9. PubMed ID: 15554995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis.
    Odin JA; Huebert RC; Casciola-Rosen L; LaRusso NF; Rosen A
    J Clin Invest; 2001 Jul; 108(2):223-32. PubMed ID: 11457875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ nucleic acid detection of PDC-E2, BCOADC-E2, OGDC-E2, PDC-E1alpha, BCOADC-E1alpha, OGDC-E1, and the E3 binding protein (protein X) in primary biliary cirrhosis.
    Harada K; Sudo Y; Kono N; Ozaki S; Tsuneyama K; Gershwin ME; Nakanuma Y
    Hepatology; 1999 Jul; 30(1):36-45. PubMed ID: 10385636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a locally driven mucosal response and the presence of mitochondrial antigens in saliva in primary biliary cirrhosis.
    Reynoso-Paz S; Leung PS; Van De Water J; Tanaka A; Munoz S; Bass N; Lindor K; Donald PJ; Coppel RL; Ansari AA; Gershwin ME
    Hepatology; 2000 Jan; 31(1):24-9. PubMed ID: 10613723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to the pathogenesis of primary biliary cirrhosis through animal models.
    Concepcion AR; Medina JF
    Clin Res Hepatol Gastroenterol; 2012 Feb; 36(1):21-8. PubMed ID: 21862437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.